Results 1 to 10 of about 72,525 (247)

Differential <i>in vivo</i> tyrosine kinase inhibitor sensitivities of pediatric ABL-class Ph-like B-acute lymphoblastic leukemia. [PDF]

Hemasphere
HemaSphere, Volume 10, Issue 9, September 2026.
Sharma R, Dardis JK, Mai HA, Arenas Merizalde C, van de Ven C, Bárcenas López DA, Bhatnagar S, Attarbaschi A, Boer JM, den Boer ML, Tasian SK.   +10 more
europepmc   +2 more sources

Non-Coding RNAs in Gastrointestinal Stromal Tumors: Regulatory Networks, Drug Resistance, and Clinical Implications. [PDF]

Int J Mol Sci
Mandrakis G, Papadakos SP, Levidou G, Keratsa P, Christodoulou MI, Theocharis S.   +5 more
europepmc   +1 more source

Patient Care of Pregnant Women With Chronic Myeloid Leukemia in a Resource Limited Setting-Case Reports From Ghana. [PDF]

Case Rep Hematol
Benneh-Akwasi Kuma A, Hanson LL, Pepra-Ameyaw NB, Obeng GD, Csanádi M.   +4 more
europepmc   +1 more source

Long-Term Offspring Outcomes Following Parental Exposure to BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Retrospective Cohort Study with Follow-Up to 24.6 Years. [PDF]

Cancers (Basel)
Pál S, Solymár M, Alizadeh H.
europepmc   +1 more source

Meta-Analysis of Imatinib Resistance in Chronic Myeloid Leukemia due to BIM Gene Deletion and Single Nucleotide Polymorphisms Reveals Ethnic Variations in Prevalence. [PDF]

EJHaem
Bhattarai A, Kountouris D, Sah S, Mehta R, Sah R.   +4 more
europepmc   +1 more source

Two novel e13a3 variants detected in CML patients and their DNA breakpoint analysis. [PDF]

Front Oncol
Liang D, Chang J, Xu Z, Ren F, Yang B, Chen X, Wang H.   +6 more
europepmc   +1 more source

Renal dysfunction in patients with CML on long-term first-line TKI therapy: a single-center analysis. [PDF]

Oncologist
Wang S, Lei Y, Liu S, Zhang B, Zhao X, Qiao C, Hong M, Qian S, Fan L, Zhu Y.   +9 more
europepmc   +1 more source

<i>KCTD5::PDGFRB</i> Fusion Gene Leading to Clonal Hypereosinophilia With Cardiac Involvement in a Young Adult: A Case Report. [PDF]

Case Rep Hematol
de Groote L, Papazoglou D, Ku J, Heimann P, Dewispelaere L, Sidon P, Roufosse F, Trépant AL, Cilla N.   +8 more
europepmc   +1 more source

Evaluation of Imatinib and Its Combination With Albendazole Against <i>Echinococcus granulosus</i> Protoscoleces and Microcysts In Vitro. [PDF]

J Parasitol Res
Hanifeh Z, Haniloo A, Torabi N, Farhadi M.   +3 more
europepmc   +1 more source

Zero-premium Medicare Advantage plans and access to generic abiraterone and imatinib. [PDF]

Health Aff Sch
Jiang C, Tang Y, Lu CA, Shih YT, Yabroff KR, Han X, Hu X.   +6 more
europepmc   +1 more source